A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression.

Abstract

The current study sought to test the efficacy and safety of the novel selective norepinephrine reuptake inhibitor LY2216684 compared to placebo in patients with major depressive disorder (MDD). Escitalopram was used as a control for assay sensitivity. Adult outpatients with MDD, confirmed at screening by the Mini International Neuropsychiatric Interview, a… (More)
DOI: 10.1016/j.jpsychires.2009.09.013

Topics

7 Figures and Tables

Cite this paper

@article{Dub2010ASO, title={A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression.}, author={Sanjay Dub{\'e} and Mary Anne Dellva and Marcia C M F Jones and William Kielbasa and Robert A. Padich and Amitabh Saha and Prasad Rao}, journal={Journal of psychiatric research}, year={2010}, volume={44 6}, pages={356-63} }